Article Figures & Data
Figures
- 1
Survival curves of patients in the HLL group and NL group.
Tables
Characteristics HLL EHLL NL Gender Female 12 (57.1) 8 (66.7) 27 (38.0) Male 9 (42.9) 4 (33.3) 44 (62.0) Age, years ≤60 15 (71.4) 6 (50.0) 41 (57.7) >60 6 (28.6) 6 (50.0) 30 (42.3) Tumor number Solitary 12 (57.1) 9 (75.0) 41 (57.7) Multiple 9 (42.9) 3 (25.0) 30 (42.3) Tumor diameter, cm ≤5 6 (28.6) 4 (33.3) 40 (56.3) >5 15 (71.4) 8 (66.7) 31 (43.7) Hepatitis B Negative 11 (52.4) 10 (83.3) 38 (53.5%) Positive 10 (47.6) 2 (16.7) 33 (46.5) Cirrhosis Negative 16 (76.2) 12 (100.0) 39 (54.9) Positive 5 (23.8) 0 (0.0) 32 (45.1) Fer Normal 6 (28.6) 6 (50.0) 41 (57.7) Higher 15 (71.4) 6 (50.0) 30 (42.3) CEA Normal 13 (61.9) 8 (66.7) 62 (87.3) Higher 8 (38.1) 4 (33.3) 9 (12.7) CA19-9 Normal 5 (23.8) 2 (16.7) 48 (67.6) Higher 16 (76.2) 10 (83.3) 23 (32.4) AFP Normal 20 (95.2) 11 (91.7) 50 (70.4) Higher 1 (4.8) 1 (8.3) 21 (29.6) AJCC stage I/II 10 (47.6) 9 (75.0) 49 (69.0) III/IVa/IVb 11 (52.4) 3 (25.0) 22 (31.0) Differentiation Poor 7 (33.3) 7 (58.3) 40 (56.3) Well or moderate 14 (66.7) 5 (41.7) 31 (43.7) Vascular invasion Negative 13 (61.9) 8 (66.7) 48 (67.6) Positive 8 (38.1) 4 (33.3) 23 (32.4) LNM Negative 15 (71.4) 7 (58.3) 71 (100.0) Positive 6 (28.6) 5 (41.7) 0 (0.0) LND HLL EHLL NL Chi-square P Chi-square P Chi-square P HLL - - 2.855 0.091 6.345 0.012 EHLL 2.855 0.091 - - 0.002 0.969 NL 6.345 0.012 0.002 0.969 - - Characteristic n Survival rate (%) P 1 year 2 years 3 years Gender 0.028 Female 47 68.1 44.0 31.1 Male 57 75.4 66.0 53.2 Age, years 0.041 ≤60 62 75.8 62.4 54.3 >60 42 66.7 46.7 27.6 Tumor number 0.503 Solitary 62 75.8 58.8 44.0 Multiple 42 66.7 52.4 43.7 Tumor diameter, cm 0.059 ≤5 50 76.0 60.9 53.7 >5 54 68.5 48.9 32.4 Hepatitis B 0.896 Negative 59 74.6 56.8 44.1 Positive 45 68.9 52.4 43.0 Liver cirrhosis 0.649 Negative 67 71.6 56.2 44.7 Positive 37 73.0 52.6 41.4 Fer 0.010 Normal 53 83.0 67.2 55.9 Higher 51 60.8 42.0 31.5 CEA 0.042 Normal 83 75.9 60.6 46.5 Higher 21 57.1 38.1 31.7 CA-199 0.038 Normal 55 80.0 62.4 52.5 Higher 49 63.3 46.2 34.6 AFP 0.632 Normal 81 70.4 54.8 43.7 Higher 23 78.3 60.6 44.2 AJCC stage 0.000 I/II 68 82.4 71.1 54.0 III/IVa/IVb 36 52.8 27.8 23.8 Differentiation 0.009 Poor 54 68.5 48.7 28.4 Well or moderate 50 76.0 63.6 59.9 Vascular invasion 0.689 Negative 69 71.0 55.9 42.5 Positive 35 74.3 56.1 46.8 LNM 0.003 Negative 93 76.3 59.5 47.8 Positive 11 36.4 27.3 0 LND 0.032 HLL 21 47.6 28.6 28.6 EHLL 12 75.0 66.7 33.3 NL 71 78.9 62.5 47.8 Clinical features B Wald P Exp (B) Exp (B) 95% CI Age – 0.607 4.841 <0.05 0.545 (0.317, 0.936) AJCC stage – 0.948 11.510 <0.05 0.388 (0.224, 0.670) Differentiation 0.602 4.494 <0.05 1.825 (1.046, 3.182) Fer 0.674 5.530 <0.05 1.962 (1.119, 3.439) LNM 1.072 7.307 <0.05 2.921 (1.343, 6.353)
